Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer
The aim of this study was to address one of the major challenges of the actual era of nanomedicine namely, the bioavailability of poorly water soluble drugs such as Silymarin. We developed new, biodegradable, and biocompatible nanosized shuttles for Silymarin targeted delivery in colon-cancer cells....
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00508/full |
id |
doaj-fcdad4a1249c459e923b88d441d6c52b |
---|---|
record_format |
Article |
spelling |
doaj-fcdad4a1249c459e923b88d441d6c52b2020-11-24T22:13:56ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-08-01810.3389/fphar.2017.00508271688Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal CancerIonut-Cristian Radu0Ariana Hudita1Catalin Zaharia2Paul O. Stanescu3Eugenia Vasile4Horia Iovu5Miriana Stan6Octav Ginghina7Octav Ginghina8Bianca Galateanu9Bianca Galateanu10Marieta Costache11Peter Langguth12Aristidis Tsatsakis13Kelly Velonia14Carolina Negrei15Advanced Polymer Materials Group, University Politehnica of BucharestBucharest, RomaniaDepartment of Biochemistry and Molecular Biology, University of BucharestBucharest, RomaniaAdvanced Polymer Materials Group, University Politehnica of BucharestBucharest, RomaniaAdvanced Polymer Materials Group, University Politehnica of BucharestBucharest, RomaniaDepartment of Bioresources and Polymer Science, University Politehnica of BucharestBucharest, RomaniaAdvanced Polymer Materials Group, University Politehnica of BucharestBucharest, RomaniaDepartment of Toxicology, Faculty of Pharmacy, Carol Davila University of Medicine and PharmacyBucharest, RomaniaDepartment of Surgery, Sf. Ioan Emergency Clinical HospitalBucharest, RomaniaDepartment II, Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy BucharestBucharest, RomaniaDepartment of Biochemistry and Molecular Biology, University of BucharestBucharest, RomaniaResearch Institute of University of Bucharest, University of BucharestBucharest, RomaniaDepartment of Biochemistry and Molecular Biology, University of BucharestBucharest, RomaniaDepartment of Pharmaceutical Technology and Biopharmaceutics, Institute of Pharmacy, Johannes Gutenberg-UniversityMainz, GermanyDepartment of Toxicology and Forensic Sciences, Faculty of Medicine, University of CreteHeraklion, Greece0Department of Materials Science and Technology, University of CreteHeraklion, GreeceDepartment of Toxicology, Faculty of Pharmacy, Carol Davila University of Medicine and PharmacyBucharest, RomaniaThe aim of this study was to address one of the major challenges of the actual era of nanomedicine namely, the bioavailability of poorly water soluble drugs such as Silymarin. We developed new, biodegradable, and biocompatible nanosized shuttles for Silymarin targeted delivery in colon-cancer cells. The design of these 100 nm sized carrier nanoparticles was based on natural polymers and their biological properties such as cellular uptake potential, cytotoxicity and 3D penetrability were tested using a colon cancer cell line (HT-29) as the in vitro culture model. Comparative scanning electron microscopy (SEM) and atomic force microscopy (AFM) measurements demonstrated that the Silymarin loaded Poly(3-HydroxyButyrate-co-3-HydroxyValerate) (PHBHV) nanocarriers significantly decreased HT-29 cells viability after 6 and 24 h of treatment. Moreover, in vivo-like toxicity studies on multicellular tumor spheroids showed that the Silymarin loaded PHBHV nanocarriers are able to penetrate 3D micro tumors and significantly reduce their size.http://journal.frontiersin.org/article/10.3389/fphar.2017.00508/fullnanocarriersdrug deliverycolo-rectal cancerSilymarinPoly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ionut-Cristian Radu Ariana Hudita Catalin Zaharia Paul O. Stanescu Eugenia Vasile Horia Iovu Miriana Stan Octav Ginghina Octav Ginghina Bianca Galateanu Bianca Galateanu Marieta Costache Peter Langguth Aristidis Tsatsakis Kelly Velonia Carolina Negrei |
spellingShingle |
Ionut-Cristian Radu Ariana Hudita Catalin Zaharia Paul O. Stanescu Eugenia Vasile Horia Iovu Miriana Stan Octav Ginghina Octav Ginghina Bianca Galateanu Bianca Galateanu Marieta Costache Peter Langguth Aristidis Tsatsakis Kelly Velonia Carolina Negrei Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer Frontiers in Pharmacology nanocarriers drug delivery colo-rectal cancer Silymarin Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) |
author_facet |
Ionut-Cristian Radu Ariana Hudita Catalin Zaharia Paul O. Stanescu Eugenia Vasile Horia Iovu Miriana Stan Octav Ginghina Octav Ginghina Bianca Galateanu Bianca Galateanu Marieta Costache Peter Langguth Aristidis Tsatsakis Kelly Velonia Carolina Negrei |
author_sort |
Ionut-Cristian Radu |
title |
Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer |
title_short |
Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer |
title_full |
Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer |
title_fullStr |
Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer |
title_full_unstemmed |
Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer |
title_sort |
poly(hydroxybutyrate-co-hydroxyvalerate) (phbhv) nanocarriers for silymarin release as adjuvant therapy in colo-rectal cancer |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2017-08-01 |
description |
The aim of this study was to address one of the major challenges of the actual era of nanomedicine namely, the bioavailability of poorly water soluble drugs such as Silymarin. We developed new, biodegradable, and biocompatible nanosized shuttles for Silymarin targeted delivery in colon-cancer cells. The design of these 100 nm sized carrier nanoparticles was based on natural polymers and their biological properties such as cellular uptake potential, cytotoxicity and 3D penetrability were tested using a colon cancer cell line (HT-29) as the in vitro culture model. Comparative scanning electron microscopy (SEM) and atomic force microscopy (AFM) measurements demonstrated that the Silymarin loaded Poly(3-HydroxyButyrate-co-3-HydroxyValerate) (PHBHV) nanocarriers significantly decreased HT-29 cells viability after 6 and 24 h of treatment. Moreover, in vivo-like toxicity studies on multicellular tumor spheroids showed that the Silymarin loaded PHBHV nanocarriers are able to penetrate 3D micro tumors and significantly reduce their size. |
topic |
nanocarriers drug delivery colo-rectal cancer Silymarin Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) |
url |
http://journal.frontiersin.org/article/10.3389/fphar.2017.00508/full |
work_keys_str_mv |
AT ionutcristianradu polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT arianahudita polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT catalinzaharia polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT paulostanescu polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT eugeniavasile polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT horiaiovu polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT mirianastan polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT octavginghina polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT octavginghina polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT biancagalateanu polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT biancagalateanu polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT marietacostache polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT peterlangguth polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT aristidistsatsakis polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT kellyvelonia polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer AT carolinanegrei polyhydroxybutyratecohydroxyvaleratephbhvnanocarriersforsilymarinreleaseasadjuvanttherapyincolorectalcancer |
_version_ |
1725799268467343360 |